Zydus Lifesciences completes 50:50 JV transaction with Sunshine Healthcare Lanka

New Delhi: Zydus Lifesciences Ltd on Thursday said it has completed the transaction to subscribe to a 50 per cent stake in Zydus Sunshine Lifesciences Pvt Ltd, making it a 50:50 joint venture alongside Sunshine Healthcare Lanka Limited.

The transaction involving the subscription of shares and formation of the joint venture was completed on November 11, 2026, according to a regulatory filing.

The company noted that there was a delay in sending the intimation due to office holidays during the festive season.


Under a share subscription and shareholders' agreement executed on June 26, 2026, the deal was initially expected to close within 90 working days.

The companies subsequently agreed on October 1, 2026, to extend the closing date to December 2026 before concluding the transaction.